1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increased Awareness About Personal Health Management
4.2.2. Benefits of DTC Laboratory Testing such as High Convenience, Affordability & Accessibility
4.2.3. Increasing Prevalence of Chronic & Infectious Diseases
4.2.4. Increasing Cost of Healthcare
4.2.5. Rising Elderly Population
4.3. Restraints
4.3.1. Sample Integrity and Interference Issues
4.3.2. Regulatory Concerns
4.3.3. Lack of Reimbursement
4.3.4. Limited Test Portfolio Compared to Conventional Laboratory Testing
4.4. Opportunities
4.4.1. Growing Adoption of Telehealth
4.4.2. Expansion in Emerging Economies
4.4.3. Increasing Penetration of Pharmacogenomic Testing in DTC Laboratory Testing
4.5. Challenges
4.5.1. Genetic Data Privacy Concerns
4.5.2. Misinterpretation of Test Results
4.5.3. Lack of Professional Medical Counselling
4.6. Industry & Technological Trends
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Adjacent/Related Markets
5. Asia-Pacific DTC Laboratory Testing Market Assessment—by Application
5.1. Overview
5.2. Genetic Testing
5.2.1. Ancestry/Genealogy
5.2.2. Disease Risk Assessment
5.2.2.1. Cancer
5.2.2.2. Cardiovascular Diseases
5.2.2.3. Neurological Diseases
5.2.2.4. Other Diseases
5.2.3. Carrier Status
5.2.4. Other Genetic Tests
5.3. Diabetes Testing
5.4. Routine Clinical Testing
5.5. Thyroid Function Testing
5.6. COVID-19 Testing
5.7. Sexually Transmitted Disease Testing
5.8. Other Applications
6. Asia-Pacific DTC Laboratory Testing Market Assessment—by Sample Type
6.1. Overview
6.2. Blood
6.3. Saliva
6.4. Urine
6.5. Other Samples
7. Asia-Pacific DTC Laboratory Testing Market Assessment—by Country
7.1. Overview
7.2. China
7.3. Japan
7.4. India
7.5. Australia
7.6. South Korea
7.7. Indonesia
7.8. Thailand
7.9. Malaysia
7.10. Singapore
7.11. Philippines
7.12. Vietnam
7.13. Rest of Asia-Pacific (RoAPAC)
8. Competition Analysis
8.1. Overview
8.2. Key Growth Strategies
8.3. Competitive Benchmarking
8.4. Competitive Dashboard
8.4.1. Industry Leaders
8.4.2. Market Differentiators
8.4.3. Vanguards
8.4.4. Emerging Companies
8.5. Market Share Analysis/Market Ranking (2022)
9. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
9.1. Metropolis Healthcare Limited (India)
9.2. SRL Limited (India)
9.3. Hirotsu Bio Science (Japan)
9.4. Mapmygenome India Limited (India)
9.5. Genesis Healthcare Co. (Japan)
9.6. Augmentum Diagnostics (India)
9.7. Apollo Health and Lifestyle Limited (India)
9.8. WeGene (China)
9.9. GeseDNATechnology LLP (China)
9.10. Laboratory Corporation of America Holdings (U.S.)
9.11. LetsGetChecked, Inc. (U.S.)
9.12. 23andMe Holding Co. (U.S.)
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
10. Appendix
10.1. Available Customization
10.2. Related Reports
List of Tables
Table 1 Asia-Pacific DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 2 Asia-Pacific Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 3 Asia-Pacific Direct-to-consumer Genetic Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 4 Asia-Pacific DTC Genetic Testing Market for Ancestry/Genealogy, by Country/Region, 2021–2030 (USD Million)
Table 5 Asia-Pacific DTC Genetic Testing Market for Diseases Risk Assessment, by Type, 2021–2030 (USD Million)
Table 6 Asia-Pacific DTC Genetic Testing Market for Diseases Risk Assessment, by Country/Region, 2021–2030 (USD Million)
Table 7 Asia-Pacific Disease Risk Assessment Testing Market for Cancer, by Country/Region, 2021–2030 (USD Million)
Table 8 Asia-Pacific Disease Risk Assessment Testing Market for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million)
Table 9 Asia-Pacific Disease Risk Assessment Testing Market for Neurological Diseases, by Country/Region, 2021–2030 (USD Million)
Table 10 Asia-Pacific Disease Risk Assessment Testing Market for Other Diseases, by Country/Region, 2021–2030 (USD Million)
Table 11 Asia-Pacific DTC Genetic Testing Market for Carrier Status, by Country/Region, 2021–2030 (USD Million)
Table 12 Asia-Pacific DTC Genetic Testing Market for Other Genetic Tests, by Country/Region, 2021–2030 (USD Million)
Table 13 Asia-Pacific DTC Diabetes Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Asia-Pacific DTC Routine Clinical Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Asia-Pacific DTC Thyroid Function Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Asia-Pacific DTC Laboratory Testing Market for COVID-19 Testing, by Country/Region, 2021–2030 (USD Million)
Table 17 Asia-Pacific DTC Laboratory Testing Market for Sexually Transmitted Diseases, by Country/Region, 2021–2030 (USD Million)
Table 18 Asia-Pacific DTC Laboratory Testing Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 19 Asia-Pacific DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 20 Asia-Pacific DTC Laboratory Testing Market for Blood, by Country/Region, 2021–2030 (USD Million)
Table 21 Asia-Pacific DTC Laboratory Testing Market for Saliva, by Country/Region, 2021–2030 (USD Million)
Table 22 Asia-Pacific DTC Laboratory Testing Market for Urine, by Country/Region, 2021–2030 (USD Million)
Table 23 Asia-Pacific DTC Laboratory Testing Market for Other Samples, by Country/Region, 2021–2030 (USD Million)
Table 24 Asia-Pacific DTC Laboratory Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 25 China: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 26 China: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 27 China: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 28 China: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 29 Japan: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 30 Japan: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 31 Japan: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 32 Japan: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 33 India: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 34 India: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 35 India: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 36 India: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 37 Australia: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 38 Australia: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 39 Australia: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 40 Australia: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 41 South Korea: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 42 South Korea: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 43 South Korea: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 44 South Korea: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 45 Indonesia: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 46 Indonesia: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 47 Indonesia: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 48 Indonesia: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 49 Thailand: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 50 Thailand: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 51 Thailand: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 52 Thailand: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 53 Malaysia: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 54 Malaysia: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 55 Malaysia: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 56 Malaysia: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 57 Singapore: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 58 Singapore: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 59 Singapore: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 60 Singapore: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 61 Philippines: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 62 Philippines: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 63 Philippines: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 64 Philippines: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 65 Vietnam: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 66 Vietnam: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 67 Vietnam: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 68 Vietnam: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 69 Rest of Asia-Pacific: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 70 Rest of Asia-Pacific: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 71 Rest of Asia-Pacific: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 72 Rest of Asia-Pacific: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 73 Recent Developments, by Company, 2020–2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for the Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Asia-Pacific DTC Laboratory Testing Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 8 Asia-Pacific DTC Laboratory Testing Market Size, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 9 DTC Laboratory Testing Market Size, by Geography
Figure 10 Asia-Pacific: DTC Laboratory Testing Market Snapshot
Figure 11 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 12 Competitive Dashboard: DTC Laboratory Testing Market
Figure 13 DTC Laboratory Testing Market: Vendor Benchmarking, by Application
Figure 14 DTC Laboratory Testing Market: Vendor Benchmarking, by Region
Figure 15 Asia-Pacific DTC Laboratory Testing Market Share Analysis, by Key Players, 2022 (%)
Figure 16 Metropolis Healthcare Ltd.: Financial Overview (2022)
Figure 17 Laboratory Corporation of America Holdings: Financial Overview (2022)
Figure 18 23andMe Holding Co.: Financial Overview (2022)
COVID-19
This report provides pre & post COVID-19 market estimates.